MFDS — authorised 19 September 1996
- Marketing authorisation holder: CONCORDIA PHARMS INC
- Status: likely_approved
🇰🇷 Nilandron in South Korea
MFDS authorised Nilandron on 19 September 1996
Marketing authorisation
Nilandron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Nilandron approved in South Korea?
Yes. MFDS authorised it on 19 September 1996.
Who is the marketing authorisation holder for Nilandron in South Korea?
CONCORDIA PHARMS INC holds the South Korean marketing authorisation.